Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN Mayo Clinic
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
UMSL esports program more than fun and games for players
Yudin Gurung and Mahde Alkharabsheh are both members of the Triton esports Valorant team, which is in its third season of competition this academic year.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN Mayo Clinic
LATEST NEWS
- UMSL esports program more than fun and games for players
- Bridge Program graduates and UMSL freshmen Kauthar Hammad, Taylor Moore and Marlo Shivers honored as Suggs Scholars
- UMSL, FOCUS St. Louis working together to grow leaders today and in the future
- UMSL Marketing and Communications wins three CASE Best of District VI Awards
- UMSL leaders showcase strategic communication and community impact at 2025 CUMU Conference
- Eric Zhang pursues passion for piano while also studying supply chain management
- Alum Georgeann McLemore returns to share her success story with current students
- Optometry student Grace Broach named to 2025-26 CooperVision Student Contact Lens Leadership Society
- UMSL Tritons weekly rewind
- Eye on UMSL: Performance time
